Tetyana Kendzerska1, Andrea S Gershon2, Clare Atzema2, Paul Dorian3, Iqwal Mangat3, Gillian Hawker4, Richard S Leung3. 1. Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada; ICES, Ottawa, ON, Canada. Electronic address: tkendzerska@toh.ca. 2. ICES, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada; Sunnybrook Research Institute, Sunnybrook Health Science Centre, Toronto, ON, Canada. 3. Department of Medicine, University of Toronto, Toronto, ON, Canada; St. Michael's Hospital, Toronto, ON, Canada. 4. ICES, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada; Women's College Research Institute, Toronto, ON, Canada.
Abstract
OBJECTIVES: This study examined the relationship between newly diagnosed OSA and incident hospitalized atrial fibrillation (AF) over the subsequent 10 years in a large arrhythmia-free cohort. METHODS: Adults referred between 1994 and 2010 to a large academic hospital with suspected OSA who were arrhythmia-free at the time of the first diagnostic sleep study were included. Clinical data were linked to provincial health administrative data to define outcome. Cox regressions were used to investigate the relationship between severity of OSA as measured by the apnea-hypopnea index (AHI) and degree of nocturnal hypoxemia, and incident hospitalized AF. RESULTS: In total, 8,256 subjects were included in this study. Their median age was 47 years, 62% were men; 28% had an AHI > 30 events per hour, and 6% spent > 30% of sleep time with oxygen saturation < 90%. Over a median follow-up of 10 years (interquartile range, 7-13 years), 173 participants (2.1%) were hospitalized with AF. Controlling for age, sex, alcohol consumption, smoking status, previous heart failure, COPD, and pulmonary embolism, nocturnal hypoxemia (but not AHI) was a significant predictor of incident AF: hazard ratio, 2.47 (95% CI, 1.64-3.71). After further controlling for BMI and hypertension, this association was attenuated but remained significant (hazard ratio, 1.77 [95% CI, 1.15-2.74]). CONCLUSIONS: In a large arrhythmia-free clinical cohort with suspected OSA, nocturnal hypoxemia was independently associated with a 77% increased hazard of incident hospitalized AF. These findings further support a relationship between OSA, nocturnal hypoxemia, and new-onset AF, and they may be used to enhance AF prevention in patients with OSA and severe nocturnal hypoxemia.
OBJECTIVES: This study examined the relationship between newly diagnosed OSA and incident hospitalized atrial fibrillation (AF) over the subsequent 10 years in a large arrhythmia-free cohort. METHODS: Adults referred between 1994 and 2010 to a large academic hospital with suspected OSA who were arrhythmia-free at the time of the first diagnostic sleep study were included. Clinical data were linked to provincial health administrative data to define outcome. Cox regressions were used to investigate the relationship between severity of OSA as measured by the apnea-hypopnea index (AHI) and degree of nocturnal hypoxemia, and incident hospitalized AF. RESULTS: In total, 8,256 subjects were included in this study. Their median age was 47 years, 62% were men; 28% had an AHI > 30 events per hour, and 6% spent > 30% of sleep time with oxygen saturation < 90%. Over a median follow-up of 10 years (interquartile range, 7-13 years), 173 participants (2.1%) were hospitalized with AF. Controlling for age, sex, alcohol consumption, smoking status, previous heart failure, COPD, and pulmonary embolism, nocturnal hypoxemia (but not AHI) was a significant predictor of incident AF: hazard ratio, 2.47 (95% CI, 1.64-3.71). After further controlling for BMI and hypertension, this association was attenuated but remained significant (hazard ratio, 1.77 [95% CI, 1.15-2.74]). CONCLUSIONS: In a large arrhythmia-free clinical cohort with suspected OSA, nocturnal hypoxemia was independently associated with a 77% increased hazard of incident hospitalized AF. These findings further support a relationship between OSA, nocturnal hypoxemia, and new-onset AF, and they may be used to enhance AF prevention in patients with OSA and severe nocturnal hypoxemia.
Authors: Tetyana Kendzerska; Richard S Leung; Clare L Atzema; George Chandy; Moussa Meteb; Atul Malhotra; Gillian A Hawker; Andrea S Gershon Journal: Sleep Med Date: 2019-09-11 Impact factor: 3.492
Authors: Cecily S Fassler; Iris Gutmark-Little; Changchun Xie; Courtney M Giannini; Donald W Chandler; Frank M Biro; Susan M Pinney Journal: J Clin Endocrinol Metab Date: 2019-12-01 Impact factor: 5.958
Authors: Jordan Cunningham; Michael Hunter; Charley Budgeon; Kevin Murray; Matthew Knuiman; Jennie Hui; David Hillman; Bhajan Singh; Alan James Journal: J Clin Sleep Med Date: 2021-10-01 Impact factor: 4.324
Authors: Morohunfolu Akinnusi; Abdul Rahman El-Masri; Yolanda Lawson; Ali Albert El-Solh Journal: Intern Emerg Med Date: 2020-08-17 Impact factor: 3.397